Graham Capital Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-43,080	Closed	-$139K	–	1349
2025 Q1	$139K	Buy	+43,080	New	+$139K	﹤0.01%	1144
2024 Q4	–	Sell	-19,773	Closed	-$214K	–	1283
2024 Q3	$214K	Buy	19,773 +5,124	+35%	+$55.4K	﹤0.01%	857
2024 Q2	$307K	Buy	+14,649	New	+$307K	0.01%	698